eShowcase: ClinicalAnalytics Version 4.0 Enhanced
TrialStat's EDC Platform Adds Graphical Reporting Features and More
TrialStat's EDC Platform Adds Graphical Reporting Features and More
TrialStat (Ottawa, Canada) announces enhancements to its Web-based ClinicalAnalytics 4.0 EDC solution including graphical reporting tools, automated post data entry validation, and optimized study management.
Version 4.0's browser configurable aggregated study reporting now allows users to isolate, retrieve, and view complex data sets, as well as evaluate and compare data sources from multiple study sources within a project. Its integrated post data entry validation automatically validates the accuracy of data across multiple forms and subjects based on a study's configuration and associated data validation rules. And its study management includes improved user permission interfaces, form level permissions, and date time controls.
TrialStat, (866) 416-7828, www.trialstat.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.
